Panel cuts gap, 2nd Covishield dose between 8-16 weeks

Tribune News Service

Updated At : 11:05 AM Mar 21, 2022 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

New Delhi, March 20

The National Technical Advisory Group on Immunisation (NTAGI) has recommended to the government to reduce the gap between the two Covishield doses, suggesting that the second shot be given between eight and 16 weeks after the first.

The current protocol is to administer the second dose at a gap of 12 to 16 weeks after the first one.

The NTAGI, however, hasn’t suggested any change of dosing for Bharat Biotech’s Covaxin, the two doses of which are given 28 days apart.

Health Ministry sources said that the NTAGI suggestion followed recent scientific evidence on the dosage effectiveness. The final decision to reduce the gap has to be taken by the ministry. —

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles